Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
slaidlaw@well.ox.ac.uk

Research groups

Carroll Group: High Consequence Emerging Viruses Group

Stephen Laidlaw

PhD

Postdoctoral Research Scientist

I am a postdoc currently researching the immune response and antivirals against SARS-CoV2 and other coronaviruses.

Recent publications

Detection of mpox and other orthopoxviruses using a lateral flow device as a point-of-care diagnostic.
Laidlaw SM. et al, (2025), Microbiology spectrum
Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2
Cornish K. et al, (2024), Open Biology, 14
Detection of Mpox and other Orthopoxviruses using a Lateral Flow Device as a Point of Care diagnostic
Laidlaw S. et al, (2024)
SARS-CoV-2 infection enhancement by Amphotericin B: Implications for disease management
Nguyen D. et al, (2024)
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Barnes E. et al, (2023), Nature Medicine, 29, 1760 - 1774

More publications